Aethlon Medical, Inc. (NASDAQ:AEMD – Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totalling 1,190,000 shares, an increase of 201.5% from the December 15th total of 394,700 shares. Based on an average daily volume of 3,000,000 shares, the short-interest ratio is presently 0.4 days.
Aethlon Medical Stock Down 0.8 %
AEMD stock opened at $0.63 on Wednesday. The firm has a market capitalization of $8.80 million, a PE ratio of -0.22 and a beta of 1.61. Aethlon Medical has a twelve month low of $0.24 and a twelve month high of $2.10. The stock’s 50 day moving average is $0.51 and its 200-day moving average is $0.44.
Analysts Set New Price Targets
A number of analysts have commented on the stock. HC Wainwright restated a “buy” rating and set a $7.00 price target on shares of Aethlon Medical in a research note on Friday, November 15th. StockNews.com started coverage on shares of Aethlon Medical in a research report on Saturday. They set a “sell” rating for the company.
About Aethlon Medical
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Featured Stories
- Five stocks we like better than Aethlon Medical
- 3 Monster Growth Stocks to Buy Now
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Learn Technical Analysis Skills to Master the Stock Market
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- ETF Screener: Uses and Step-by-Step Guide
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.